Aloperine is widely studied for its anti-inflammatory and immunomodulatory properties. It is used in research related to autoimmune diseases due to its ability to suppress pro-inflammatory cytokines. It shows potential in treating conditions like rheumatoid arthritis and multiple sclerosis by modulating T-cell activity and reducing inflammation. It also exhibits antiviral activity, particularly against viruses such as influenza and hepatitis B, making it a candidate for antiviral drug development. In cancer research, aloperine has demonstrated the ability to inhibit the growth of certain tumor cells by inducing apoptosis and blocking cell cycle progression, especially in breast, liver, and colon cancer lines. Additionally, it has neuroprotective effects and is being explored for use in neurodegenerative disorders. Its natural origin and low toxicity profile enhance its appeal for development in therapeutic applications.